Mr. Beck joined Context in January 2022 as SVP of Operations. He is a pharmaceutical leader with a proven track record in strategy execution and program management capabilities. His 30-year career spans private, public, startup and high growth Pharmaceutical and Biotech companies. Prior to joining the Company, Mr. Beck served as Vice President Program Management at Galera Therapeutics where he was responsible for the design and implementation of an operations management methodology that drove execution across R&D, CMC, and Commercial functions. His other startup experience includes VP of Program Management roles at Aevi Genomics, and Formular Pharmaceuticals. Mr. Beck also held program management leadership positions at Shire Pharmaceuticals, Merck and Co., and AstraZeneca.

Mr. Beck holds a B.S. Business Administration degree from Drexel University and an MBA from Pennsylvania State University.

Read More

Mr. Lehr is the Co-founder and CEO of Context Therapeutics. In addition, Mr. Lehr is a member of the Scientific Advisory Board of Integral Molecular, an antibody discovery company.  Previously, Martin was part of the founding team at Osage University Partners, a venture capital fund focused on academic spinouts from leading research institutions. At Osage, Martin focused on early stage oncology and rare disease opportunities. Prior to Osage, Martin conducted research at the Sloan Kettering Institute in DNA repair and at the Children’s Hospital of Philadelphia in thrombosis and hemostasis.  In addition to his role at Context, Martin is the Director of Philly BioBreak, a biotech executive peer group with over 2,500 active members across the United States. He holds an M.A. in Biotechnology from Columbia University and a B.A. in Economics from the University of Pennsylvania.

+ LinkedIn

Read More

Erin Zebrowski is the Senior Director of Quality at Context Therapeutics. She is responsible for all aspects of GMP/GCP/GLP quality for the organization. Erin has more than 15 years’ experience in the pharmaceutical industry in various analytical and quality assurance roles. Prior to joining Context, she has held various technical positions at Becton Dickinson, UPM Pharmaceuticals, Nutramax Laboratories, Eisai Inc., Epicur Pharma, and TG Therapeutics.

Erin holds a BS degree in Chemistry from York College of Pennsylvania and an MPS in Biotechnology (Regulatory Track) from University of Maryland Baltimore County.

Read More